
Functional Gains After PAAG Injections in Knee Osteoarthritis: Insights from Oxford Knee and Lysholm Scores
Discover how polyacrylamide hydrogel (PAAG) injections offer a minimally invasive treatment for knee osteoarthritis (OA), delivering significant pain relief and improved mobility. This article reviews research showing that PAAG can enhance quality of life for up to two years, as measured by the Oxford Knee Score (OKS) and Lysholm score. Learn which patients—such as older adults, those with less severe OA, and individuals without diabetes—are most likely to benefit, and find out how meaningful score improvements translate to greater independence in daily activities. Explore why careful patient selection is vital and why PAAG injections represent a promising middle ground between conservative management and knee surgery.








